verapamil and Cardiomyopathy, Hypertrophic Obstructive studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research Excerpts

Excerpt	Relevance	Reference
" Verapamil remains the most widely used calcium antagonist for the treatment of cardiac arrhythmias."	8.76	Verapamil in cardiac arrhythmias: an overview. ( Vohra, J, 1982)
"We identified that carvedilol, a β-blocker not commonly used in HCM, suppresses contractile function and arrhythmia by inhibiting RyR2 (ryanodine receptor type 2)."	8.31	Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. ( Ashley, EA; Bernstein, D; Huang, Y; Kawana, M; Kirillova, A; Lane, KV; Parikh, VN; Perez, MV; Pruitt, BL; Seo, K; Wang, Q; Wheeler, MT; Wu, JC; Yadav, S; Yamamoto, Y, 2023)
"Effect of verapamil on myocardial ischemia in patients with hypertrophic cardiomyopathy (HCM) was evaluated by exercise stress myocardial 201Tl SPECT (EX-Tl)."	7.68	[Effect of verapamil on myocardial ischemia in patients with hypertrophic cardiomyopathy: evaluation by exercise 201Tl SPECT]. ( Azuma, A; Kohno, Y; Nakagawa, M; Nakagawa, T; Nakamura, T; Ootsuki, K; Shiga, K; Sugihara, H; Taniguchi, Y; Umamoto, I, 1993)
"A 17-year old boy with hypertrophic obstructive cardiomyopathy (HOCM) developed repeated short runs of self terminating ventricular tachycardia 12 hours after starting oral verapamil, which was substituted for propranolol therapy."	7.67	Verapamil-induced ventricular tachycardia in hypertrophic cardiomyopathy. ( Dettmann, R; Heintzen, PH; Seiffert, P; Wessel, A, 1987)
" Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease."	4.77	Calcium antagonists in patients with cardiovascular disease. Current perspectives. ( Hillis, LD; Winniford, MD, 1985)
" Nifedipine and diltiazem are effective in the relief of angina, and verapamil is used in the treatment of supraventricular tachyarrhythmias."	4.77	Calcium channel blocking agents: physiologic basis of nursing intervention. ( Touloukian, JE, 1985)
" Verapamil remains the most widely used calcium antagonist for the treatment of cardiac arrhythmias."	4.76	Verapamil in cardiac arrhythmias: an overview. ( Vohra, J, 1982)
"We identified that carvedilol, a β-blocker not commonly used in HCM, suppresses contractile function and arrhythmia by inhibiting RyR2 (ryanodine receptor type 2)."	4.31	Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. ( Ashley, EA; Bernstein, D; Huang, Y; Kawana, M; Kirillova, A; Lane, KV; Parikh, VN; Perez, MV; Pruitt, BL; Seo, K; Wang, Q; Wheeler, MT; Wu, JC; Yadav, S; Yamamoto, Y, 2023)
"Effect of verapamil on myocardial ischemia in patients with hypertrophic cardiomyopathy (HCM) was evaluated by exercise stress myocardial 201Tl SPECT (EX-Tl)."	3.68	[Effect of verapamil on myocardial ischemia in patients with hypertrophic cardiomyopathy: evaluation by exercise 201Tl SPECT]. ( Azuma, A; Kohno, Y; Nakagawa, M; Nakagawa, T; Nakamura, T; Ootsuki, K; Shiga, K; Sugihara, H; Taniguchi, Y; Umamoto, I, 1993)
"Sudden death was recorded by continuous ambulatory electrocardiographic (Holter) monitoring in a 62 year old man with hypertrophic cardiomyopathy and atrial fibrillation, who had been treated for four days with verapamil 360 mg orally."	3.67	Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy. ( Danchin, N; Perrot, B; Terrier de la Chaise, A, 1984)
"A 17-year old boy with hypertrophic obstructive cardiomyopathy (HOCM) developed repeated short runs of self terminating ventricular tachycardia 12 hours after starting oral verapamil, which was substituted for propranolol therapy."	3.67	Verapamil-induced ventricular tachycardia in hypertrophic cardiomyopathy. ( Dettmann, R; Heintzen, PH; Seiffert, P; Wessel, A, 1987)
"Verapamil treatment was able to restore adequate vasodilator response to pacing stress."	2.70	Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy. ( Dimitrow, PP; Dubiel, JS; Grodecki, J; Kawecka-Jaszcz, K; Krzanowski, M; Lelakowski, J; Małecka, B; Szczeklik, A, 2002)
"Verapamil blunted the increase of the coronary vascular resistance index to the CPT in comparison with its change at CPT after propranolol."	2.69	Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. ( Dimitrow, PP; Dubiel, JS; Krzanowski, M; Nizankowski, R; Szczeklik, A, 2000)
"Dipyridamole MBF was 1."	2.69	Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. ( Boyd, H; Camici, PG; Choudhury, L; Elliott, P; Lammertsma, AA; McKenna, WJ; Rimoldi, O; Ryan, M, 1999)
"The chronic effect on ventricular extrasystoles of the degrees of severity mostly II-IV were investigated in the open experiment on 17 patients as well as on 3 patients with supraventricular dysrhythmias and on 30 patients with ventricular extrasystoles Lown III-IV in the single blind cross-over experiments to verapamil retard."	2.67	[Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug]. ( Assmann, I; Kassel, P; von Knorre, G, 1990)
"verapamil treatment, HR decreased (-16%, p < 0."	2.67	Acute intravenous versus chronic oral drug effects of verapamil on left ventricular diastolic function in patients with hypertrophic cardiomyopathy. ( Blanksma, PK; Lie, KI; Posma, JL; Van der Wall, E, 1994)
"Verapamil has been shown to ameliorate silent myocardial perfusion defects documented by thallium-201 in patients with HC."	2.67	Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. ( Camici, PG; Cecchi, F; Choudhury, L; Gistri, R; Montereggi, A; Salvadori, PA; Sorace, O, 1994)
" No correlation could be found between the change in clinical symptoms and electrocardiographic, echocardiographic or hemodynamic data, nor to the dosage of V or P administered."	2.66	Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study. ( Biamino, G; Bubenheimer, P; Förster, K; Hanrath, P; Hopf, R; Kaltenbach, M; Kober, G; Kuck, KH; Schlepper, M; von Olshausen, KE, 1987)
"Verapamil was better tolerated generally and by the heart than propranolol."	2.66	[Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy]. ( Casset, D; Cosnay, P; Fauchier, JP; Itti, R; Lang, M; Lavigne, G; Raynaud, P, 1987)
"Physicians treating hypertrophic cardiomyopathy (HCM) are faced with unique management challenges."	2.43	Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment. ( Musat, D; Sherrid, MV, 2006)
"The prevalence of hypertrophic cardiomyopathy is approximately 0."	2.41	[Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum]. ( Veselka, J, 2001)
"Verapamil is a slow-channel calcium-blocking agent that has been released recently by the Food and Drug Administration for treatment of cardiac dysrhythmias in all age groups."	2.36	Verapamil: an effective calcium blocking agent for pediatric patients. ( Garson, A; Gillette, PC; Porter, CJ, 1983)
"Verapamil was the first of a class of agents known as calcium entry blockers to be released for clinical use in the United States."	2.36	The clinical use of verapamil. ( Holmes, DR; McGoon, MD; Osborn, JE; Vlietstra, RE, 1982)
"Disopyramide was added in 221 (74%) patients and pharmacological control of symptoms was achieved in 141 (64%) patients."	1.39	Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil. ( Alviar, CL; Balaram, SK; Homel, P; Kim, B; Musat, D; Sherrid, MV; Shetty, A; Swistel, DG; Winson, G, 2013)
"Drug treatment of hypertrophic cardiomyopathy is the first-line treatment, at the onset of clinical signs and symptoms."	1.35	[Drug treatment for hypertrophic cardiomyopathy]. ( Gibelin, P, 2009)
"Hypertrophic cardiomyopathy is associated with the human lymphocyte antigen (HLA DR3), and this may provide a possible link with SSc, as this HLA phenotype is common in the latter condition."	1.33	Hypertrophic cardiomyopathy in systemic sclerosis. A report of two cases. ( Anastasiadis, G; Moyssakis, I; Papadopoulos, DP; Vlachoyannopoulos, P, 2006)
"A 60-year-old man with polyarteritis nodosa under treatment presented with syncope."	1.32	Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association? ( Moyssakis, I; Papadopoulos, DP; Votteas, VE, 2004)
"Verapamil was able to restore adequate vasodilator response to handgrip exercise."	1.31	The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patients with hypertrophic cardiomyopathy. ( Dimitrow, PP; Dubiel, JS; Krzanowski, M; Nitankowski, R; Szczeklik, A, 2001)
"Verapamil treatment did not restore the forward pattern of systolic blood flow but decreased diastolic blood flow velocity to a level comparable with that in healthy subjects."	1.31	Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. ( Dubiel, JS; Krzanowski, M; Nizankowski, R; Petkow Dimitrow, P; Szczeklik, A, 2000)
"Dipyridamole-assessed CFR, was weakly related to parameters of exercise capacity."	1.29	Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. ( Bodzoń, W; Dimitrow, PP; Dubiel, JS; Krzanowski, M; Szczeklik, A, 1996)
"In sustained ventricular tachycardia (VT) unrelated to coronary artery disease, the incidence of reentry with an excitable gap was examined, and rapid pacing was performed to entrain VT in 48 episodes in 42 consecutive patients."	1.29	Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease. ( Aizawa, Y; Kitazawa, H; Kusano, Y; Naitoh, N; Shibata, A; Uchiyama, H; Washizuka, T, 1993)
"In contrast, ventricular tachycardia induction was uncommon in all of the young patients (27% in those with cardiac arrest or syncope; 0% in the others)."	1.29	Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. ( Bonow, RO; Dilsizian, V; Epstein, SE; Fananapazir, L, 1993)
" In medically treated patients, long-term administration of beta-blockers or verapamil is beneficial even without symptoms as it appears to improve prognosis."	1.27	Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy. ( Gobet, D; Haberer, T; Krayenbuehl, HP; Rothlin, ME; Senning, A; Turina, M, 1983)
" The findings of this study indicate that in patients with hypertrophic cardiomyopathy, hemodynamic improvement at rest and during exercise can be achieved by chronic administration of verapamil."	1.27	Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy. ( Bleifeld, W; Diemert, J; Hanrath, P; Schlüter, M; Sonntag, F, 1983)
"Verapamil, 0."	1.27	Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy. ( Crowley, DC; Rocchini, AP; Rosenthal, A; Spicer, RL; Vasiliades, J, 1983)
"Ventricular arrhythmias were classified in a modified Lown classification: 1."	1.27	[Risk of stress-induced ventricular arrhythmias in hypertrophic cardiomyopathy]. ( Borggrefe, M; Christoph, I; Königer, HH; Lösse, B, 1984)
"They also have great potential for the treatment of hypertension, cerebrovascular disorders, and Raynaud's phenomenon."	1.27	Calcium channel blocking drugs. Part II: Clinical applications. ( Brill, DM; Fozzard, HA, 1985)
"The mechanisms underlying the cause of sudden death have not been clearly elucidated."	1.27	[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. ( Kleinebenne, A; McKenna, WJ, 1985)
"Ventricular arrhythmias, especially sustained attacks of ventricular tachycardia systematically detected by ambulant ECG, ought to be prevented by anti-arrhythmics: beta-blockers, in combination or not with anti-arrhythmics of class I, amiodarone, propafenone, etc."	1.27	[Treatment of hypertrophic cardiomyopathy]. ( Bouhour, JB; Lefèvre, M; Letard, G, 1985)
"The ophthalmic examination of patients with hypertrophic cardiomyopathy treated with high doses of verapamil over a considerable period of time showed no evidence of a side effect of the drug, thus proving its ocular safety."	1.27	Evaluation of the ocular safety of verapamil. Scheimpflug photography with densitometric image analysis of lens transparency in patients with hypertrophic cardiomyopathy subjected to long-term therapy with high doses of verapamil. ( Dragomirescu, V; Hockwin, O; Kozamanoglu, K; Kremer, F; Laser, H; Ohrloff, C, 1984)
"A case of orthostatic hypotension due to the combination of hypertrophic obstructive cardiomyopathy and autonomic failure is described."	1.27	Orthostatic hypotension due to hypertrophic cardiomyopathy and autonomic failure. ( Mader, SL; Wong, M, 1987)
"Verapamil treatment in hypertrophic cardiomyopathy is a valuable approach by which symptomatic improvement and a favourable effect on some left ventricular functions can be achieved."	1.27	Use of verapamil in the treatment of hypertrophic cardiomyopathy. ( Cervenka, V; Dvorák, J; Gregor, P; Sládková, T; Vísek, V; Widimský, P, 1986)
" Clinical trials have suggested that long-term administration of verapamil in patients with hypertrophic cardiomyopathy promotes improvement in symptomatic status and exercise tolerance in many but not all patients; similar results have been reported in preliminary studies using nifedipine."	1.27	Use of calcium channel blockers in hypertrophic cardiomyopathy. ( Lorell, BH, 1985)
"Calcium-channel blockers are useful for the treatment of hypertrophic cardiomyopathy (HCM), but, their adverse effects, especially, those of diltiazem, have not been of much concern."	1.27	Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy. ( Doiuchi, J; Hamada, M; Ito, T; Kokubu, T; Ochi, T, 1985)
"The verapamil-induced increase in peak left ventricular filling rate at rest (from 3."	1.27	Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. ( Bacharach, SL; Bonow, RO; Dilsizian, V; Green, MV; Maron, BJ; Rosing, DR, 1985)

Research

Studies (222)

Authors

Clinical Trials (8)

Trial Overview

Trial Outcomes

Change in Number of Absence Seizures From Week 8 (Baseline) to Week 12

Timeframe	Studies, this research(%)	All Research%
pre-1990	144 (64.86)	18.7374
1990's	52 (23.42)	18.2507
2000's	18 (8.11)	29.6817
2010's	6 (2.70)	24.3611
2020's	2 (0.90)	2.80

Authors	Studies
De Jong, HN	1
Dewey, FE	1
Cordero, P	1
Victorio, RA	1
Kirillova, A	2
Huang, Y	2
Madhvani, R	1
Seo, K	2
Werdich, AA	1
Lan, F	1
Orcholski, M	1
Liu, WR	1
Erbilgin, A	1
Wheeler, MT	2
Chen, R	1
Pan, S	1
Kim, YM	1
Bommakanti, K	1
Marcou, CA	1
Bos, JM	1
Haddad, F	1
Ackerman, M	1
Vasan, RS	1
MacRae, C	1
Wu, JC	2
de Jesus Perez, V	1
Snyder, M	1
Parikh, VN	2
Ashley, EA	2
Yamamoto, Y	1
Kawana, M	1
Yadav, S	1
Wang, Q	1
Lane, KV	1
Pruitt, BL	1
Perez, MV	1
Bernstein, D	1
Sherrid, MV	3
Shetty, A	1
Winson, G	1
Kim, B	1
Musat, D	2
Alviar, CL	1
Homel, P	1
Balaram, SK	1
Swistel, DG	1
Stöhr, A	1
Friedrich, FW	1
Flenner, F	1
Geertz, B	1
Eder, A	1
Schaaf, S	1
Hirt, MN	1
Uebeler, J	1
Schlossarek, S	1
Carrier, L	1
Hansen, A	1
Eschenhagen, T	1
Sorajja, P	1
Ommen, SR	1
Nishimura, RA	1
Kawasaki, T	1
Sugihara, H	2
Gibelin, P	1
Kajimoto, K	1
Imai, T	1
Minami, Y	1
Kasanuki, H	1
Cotrim, CA	1
Adame, PR	1
Pereira, HH	1
Boon, D	1
van Goudoever, J	1
Huijskes, R	1
Piek, JJ	1
van Montfrans, GA	1
Hamid, MS	1
Gimeno, JR	1
Valdes, M	1
Elliott, PM	1
Favale, S	1
Pappone, C	1
Nacci, F	1
Fino, F	1
Resta, F	1
Dicandia, CD	1
Maron, BJ	17
McKenna, WJ	6
Danielson, GK	2
Kappenberger, LJ	1
Kuhn, HJ	1
Seidman, CE	2
Shah, PM	1
Spencer, WH	1
Spirito, P	2
Ten Cate, FJ	1
Wigle, ED	1
Papadopoulos, DP	2
Moyssakis, I	2
Votteas, VE	1
Kim, HK	1
Kim, YJ	1
Sohn, DW	1
Park, YB	1
Choi, YS	1
Anastasiadis, G	1
Vlachoyannopoulos, P	1
Ridjab, D	1
Koch, M	1
Zabel, M	1
Schultheiss, HP	1
Morguet, AJ	1
Borja, J	1
Izquierdo, I	1
Guindo, J	1
Melacini, P	1
Bobbo, F	1
Basso, C	1
Tokajuk, B	1
Zucchetto, M	1
Thiene, G	1
Iliceto, S	1
Stone, KS	1
Scordo, KA	1
Koide, T	1
Kakihana, M	1
Takabatake, Y	2
Iizuka, M	1
Uchida, Y	1
Ozeki, K	1
Morooka, S	1
Kato, A	1
Tanaka, S	1
Oya, T	1
Momomura, S	1
Murao, S	1
Kumana, CR	1
Mahon, WA	1
Canedo, MI	1
Frank, MJ	1
Karlsberg, RP	1
Leon, MB	3
Cohen, LS	1
Rosing, DR	14
Epstein, SE	13
Krikler, DM	2
Rowland, E	2
Ellrodt, AG	1
Singh, BN	1
Kuhn, H	7
Gietzen, F	3
Mercier, J	1
Lösse, B	6
Köhler, E	2
Schulte, HD	4
Bircks, W	2
Loogen, F	5
Fyke, FE	1
Vlietstra, RE	2
Beynen, FM	1
Kisliak, OA	1
Storozhakov, GI	1
Johnston, WE	1
Lowenstein, E	1
Tullio, D	1
Valerio, A	1
D'Agostino, F	1
Porter, CJ	1
Garson, A	1
Gillette, PC	1
Crittin, J	1
Mayor, C	1
Bloch, A	1
Haberer, T	2
Hess, OM	5
Jenni, R	3
Krayenbühl, HP	3
Hanrath, P	4
Mathey, DG	2
Siegert, R	1
Bleifeld, W	3
Eldar, M	1
Hod, H	1
Battler, A	1
Rotstein, Z	1
Feldman, S	1
Rabinowitz, B	1
Neufeld, HN	1
Perrot, B	1
Danchin, N	1
Terrier de la Chaise, A	1
Fedorova, IF	2
Bonandi, L	1
Grimm, J	2
Anderson, DM	1
Raff, GL	1
Ports, TA	1
Brundage, BH	1
Parmley, WW	1
Chatterjee, K	1
Spicer, RL	3
Rocchini, AP	3
Crowley, DC	3
Rosenthal, A	3
Guo, HS	1
Hockwin, O	1
Dragomirescu, V	1
Laser, H	1
Ohrloff, C	1
Kozamanoglu, K	1
Kremer, F	1
Christoph, I	1
Borggrefe, M	1
Königer, HH	1
Weinrauch, LA	1
Belok, S	1
D'Elia, JA	1
Rossi, LP	1
Antman, EM	1
Vasiliades, J	1
Thompson, DS	2
Wilmshurst, P	1
Juul, SM	2
Waldron, CB	1
Jenkins, BS	2
Coltart, DJ	1
Webb-Peploe, MM	2
Bonow, RO	13
Frederick, TM	2
Bacharach, SL	7
Green, MV	6
Goose, PW	1
Morris, DL	1
Goldschlager, N	1
Tendera, M	4
Polonski, L	4
Kozielska, E	1
Schlüter, M	1
Sonntag, F	2
Diemert, J	1
Ostrow, HG	1
Cannon, RO	2
Lipson, LC	3
Kent, KM	7
TenCate, FJ	1
Serruys, PW	1
Mey, S	1
Roelandt, J	1
Zhao, ZL	1
Zeng, XH	1
Kober, G	6
Schmidt-Moritz, A	1
Hopf, R	14
Kaltenbach, M	12
Goodwin, JF	3
Oakley, CM	2
Rothlin, ME	1
Gobet, D	1
Krayenbuehl, HP	3
Turina, M	3
Senning, A	2
Vohra, J	1
Hasin, Y	1
Lewis, BS	1
Lewis, N	1
Weiss, AT	1
Gotsman, MS	1
Abinader, EG	1
Rauchfleisch, S	1
Naschitz, J	1
Condit, J	2
Dargie, H	1
Krikler, D	1
Masini, V	2
Ceci, V	1
Malinconico, U	1
Milazzotto, F	2
McGoon, MD	1
Holmes, DR	1
Osborn, JE	1
Vaisrub, S	1
Talano, JV	1
Feerst, D	1
Kremer, P	1
Lemke, R	1
Thelen, U	1
Leuner, C	1
Bluschke, V	1
Arbogast, RC	1
White, RS	1
Condit, JR	1
Harris, L	1
Perez, G	1
Oakley, C	1
Brener, Y	1
Kauli, N	1
Hirose, K	1
Shimada, T	1
Matsumura, T	1
Iwata, M	1
Yasunaga, K	1
Hori, K	1
Matsusaka, J	1
Gras, D	1
de Place, C	1
Le Breton, H	1
Leclercq, C	1
Paillard, F	1
Mabo, P	1
Daubert, C	1
Desnos, M	1
Hagège, A	1
Guérot, C	1
Sigwart, U	1
Tascón, JC	1
Albarrán, A	1
Andreu, J	1
Alonso, M	1
Posma, JL	1
Blanksma, PK	1
Van der Wall, E	1
Lie, KI	1
Gistri, R	1
Cecchi, F	1
Choudhury, L	2
Montereggi, A	1
Sorace, O	1
Salvadori, PA	1
Camici, PG	2
Zack, PM	1
Blausey, WL	1
Dilsizian, V	2
Fananapazir, L	2
Kass, DA	1
Wolff, MR	1
Ting, CT	1
Liu, CP	1
Chang, MS	1
Lawrence, W	1
Maughan, WL	1
Aizawa, Y	2
Naitoh, N	1
Kitazawa, H	1
Kusano, Y	1
Uchiyama, H	1
Washizuka, T	1
Shibata, A	2
Tamborini, G	1
Pepi, M	1
Susini, G	1
Salvi, L	1
Fiorentini, C	1
Barbier, P	1
Bartorelli, AL	1
Dimitrow, PP	7
Dubiel, JS	9
Taniguchi, Y	1
Ootsuki, K	1
Umamoto, I	1
Nakagawa, T	1
Shiga, K	1
Nakamura, T	1
Azuma, A	1
Kohno, Y	1
Nakagawa, M	1
Schneeweiss, A	1
Bartoszewski, A	1
Wodniecki, J	3
Salamon, A	1
Gilligan, DM	1
Chan, WL	1
Joshi, J	1
Clarke, P	1
Fletcher, A	1
Krikler, S	1
Fan, J	1
Zhang, Y	1
Zhang, M	1
Shen, O	1
Entebi, E	1
Yagel, S	1
Hartmann, A	1
Schnell, J	1
Kneissl, G	1
Villa Alcázar, M	1
Pellicer Martínez, A	1
Burgueros Valero, M	1
Quero Jiménez, J	1
Krzanowski, M	6
Bodzoń, W	1
Szczeklik, A	6
Vitale, DF	2
Calabrò, R	2
De Cristofaro, M	2
Pacileo, G	2
Caso, P	1
Gerundo, G	1
Bordini, C	1
Losi, MA	1
Rengo, C	1
Rengo, F	1
Gleichmann, U	1
Seggewiss, H	1
D'hahan, N	1
Taouil, K	1
Dassouli, A	1
Morel, JE	1
Gunsburg, DZ	1
Pearle, G	1
Surdacki, A	2
Steenbergen, JA	1
Stauffer, VL	1
Moran, AM	1
Colan, SD	1
Korovina, EP	1
Elliott, P	1
Rimoldi, O	1
Ryan, M	1
Lammertsma, AA	1
Boyd, H	1
Nizankowski, R	3
Ostman-Smith, I	1
Wettrell, G	1
Riesenfeld, T	1
Petkow Dimitrow, P	1
Russo, MG	1
Sarubbi, B	1
Pisacane, C	1
Nitankowski, R	1
Veselka, J	1
Grodecki, J	1
Małecka, B	1
Lelakowski, J	1
Kawecka-Jaszcz, K	1
Keller, M	3
Bussmann, WD	2
Petersen, Y	3
Schmidt, E	1
Most, E	1
Bender, F	1
Gradaus, D	1
Citone, C	1
Romei, E	1
Dini, P	1
Schmid, P	1
Pavek, P	1
Klein, W	1
Borer, JS	1
Seides, SF	1
Tripodi, D	1
Panza, JA	1
Jaśkiewicz, J	1
Zmudka, K	1
Brzostek, T	1
Assmann, I	1
Kassel, P	1
von Knorre, G	1
Kardaszewicz, P	1
Emoto, R	1
Yokota, Y	1
Miki, T	2
Usuki, S	1
Nomura, H	1
Takeuchi, Y	1
Nakatani, M	1
Fukuzaki, H	1
Woodcock, BG	1
Kirsten, R	1
Nelson, K	1
Rietbrock, S	1
Toshima, H	2
Seiler, C	2
Schoenbeck, M	2
Turina, J	2
Chahine, RA	1
Gwathmey, JK	1
Warren, SE	1
Briggs, GM	1
Copelas, L	1
Feldman, MD	1
Phillips, PJ	1
Callahan, M	1
Schoen, FJ	1
Grossman, W	1
Morgan, JP	1
Pelliccia, F	1
Cianfrocca, C	1
Romeo, F	1
Reale, A	1
Nitta, Y	1
Shimizu, M	1
Kita, Y	1
Konishi, K	1
Kawagoshi, H	1
Umeda, K	1
Takeda, R	1
Bunko, H	1
Hisada, K	1
Genda, A	1
Cohen, IL	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy-- a Multicenter Randomized Control Trial[NCT02948998]	Phase 4	260 participants (Anticipated)	Interventional	2018-05-14	Not yet recruiting
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy[NCT04133532]	Phase 4	22 participants (Actual)	Interventional	2020-03-05	Completed
Correlation Between Myocardial Deformation and Coronary Artery Morphology in Patients With Hypertrophic Cardiomyopathy and Analysis of Genetic Factors：A Prospective, Single-center, Case-control Study[NCT04830787]		302 participants (Actual)	Observational	2017-12-01	Completed
Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome[NCT01607073]	Phase 2	2 participants (Actual)	Interventional	2012-04-30	Completed
Myocardial Ultrasonic Tissue Characterization in Patients With a Genetic Predisposition for the Development of Hypertrophic Cardiomyopathy[NCT00001632]		195 participants	Observational	1997-09-30	Completed
H215O Positron Emission Tomography (PET) in the Assessment of Synovial Blood Flow in Rheumatoid Arthritis Patients[NCT00014794]	Phase 1	10 participants	Interventional	2001-04-30	Completed
Obstructive Hypertrophic Cardiomyopathy (HCM) in Children: Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy[NCT00001396]	Phase 1	100 participants	Interventional	1993-10-06	Completed
Long-Term Results of DDD Pacing in Obstructive Hypertrophic Cardiomyopathy[NCT00001530]		120 participants	Observational	1996-04-30	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

The secondary outcome measure is the change in number of absence seizures from Week 8 (Baseline) to Week 12 (NCT01607073)
Timeframe: Week 8 to Week 12

Change in Number of General Tonic-clonic Seizures From Week 8 (Baseline) Visit to Week 12 Visit

Intervention	Abscence seizures (Number)
Week 8 Baseline	165
Week 12 Verapamil 4mg/kg/Day	101

The primary study endpoint is the change in number of seizures from baseline. Since we only had one participant finish the study, the endpoint was changed to Week 12 visit. Participants were on verapamil for 4 weeks at Week 12. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12

Change in Number of Myoclonic Seizures From Week 8 (Baseline) to Week 12

Intervention	General tonic-clonic seizures (Number)
Week 8 Baseline	39
Week 12 Verapamil 4mg/kg/Day	14

The secondary outcome is the change in number of myoclonic seizures between baseline Week 8 visit and Week 12 visit. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12

Reviews

Trials

Other Studies

169 other studies available for verapamil and Cardiomyopathy, Hypertrophic Obstructive

Article	Year
Subendocardial ischemia in hypertrophic cardiomyopathy. Journal of cardiology, 2014, Volume: 63, Issue:2 Topics: Bridged Bicyclo Compounds, Heterocyclic; Cardiomyopathy, Hypertrophic; Diagnostic Imaging; Diltiazem	2014
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European S Journal of the American College of Cardiology, 2003, Nov-05, Volume: 42, Issue:9 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial;	2003
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European S Journal of the American College of Cardiology, 2003, Nov-05, Volume: 42, Issue:9 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial;	2003
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European S Journal of the American College of Cardiology, 2003, Nov-05, Volume: 42, Issue:9 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial;	2003
American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European S Journal of the American College of Cardiology, 2003, Nov-05, Volume: 42, Issue:9 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Pacing, Artificial;	2003
Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2006, Volume: 6 Suppl 2 Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Hypertrophic; Decision Trees; Defibrillators, Implantab	2006
Understanding the calcium channel blockers. Heart & lung : the journal of critical care, 1984, Volume: 13, Issue:5 Topics: Action Potentials; Angina Pectoris; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Calcium; Calciu	1984
Clinical value of calcium antagonists in treatment of cardiovascular disorders. Journal of the American College of Cardiology, 1983, Volume: 1, Issue:1 Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calciu	1983
Clinical applications of slow channel blocking compounds. Pharmacology & therapeutics, 1983, Volume: 23, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Platelets; Blood Vessels; Calcium	1983
Calcium channel blocking drugs. Contemporary anesthesia practice, 1983, Volume: 7 Topics: Anesthesia; Angina Pectoris; Animals; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophi	1983
[Calcium antagonists in cardiology]. La Clinica terapeutica, 1983, Jan-15, Volume: 104, Issue:1 Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Coronary Disease; Dilt	1983
Verapamil: an effective calcium blocking agent for pediatric patients. Pediatrics, 1983, Volume: 71, Issue:5 Topics: Administration, Oral; Adult; Aged; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiomy	1983
Verapamil in cardiac arrhythmias: an overview. Clinical and experimental pharmacology & physiology. Supplement, 1982, Volume: 6 Topics: Administration, Oral; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blo	1982
Hypertrophic cardiomyopathy: an overview. Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2 Topics: Adolescent; Adult; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathy, Hypertrophic; Child; Child,	1980
Role of calcium antagonists in cardiovascular therapy. British heart journal, 1981, Volume: 46, Issue:1 Topics: Angina Pectoris; Arrhythmias, Cardiac; Blood Vessels; Calcium; Calcium Channel Blockers; Cardiomyopa	1981
The natural history of hypertrophic cardiomyopathy. Current problems in cardiology, 1981, Volume: 6, Issue:4 Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Humans; Nifedipine; P	1981
Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy. Giornale italiano di cardiologia, 1981, Volume: 11, Issue:11 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Pindolol; Verapa	1981
The clinical use of verapamil. Mayo Clinic proceedings, 1982, Volume: 57, Issue:8 Topics: Administration, Oral; Adult; Animals; Arrhythmias, Cardiac; Biological Availability; Calcium; Cardio	1982
[Early surgical treatment of symptomatic hypertrophic obstructive myocardiopathy. Arguments against]. Revista espanola de cardiologia, 1995, Volume: 48, Issue:4 Topics: Adrenergic beta-Antagonists; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; D	1995
[Hypertrophic cardiomyopathy in a low-birth-weight newborn treated with dexamethasone]. Anales espanoles de pediatria, 1996, Volume: 44, Issue:4 Topics: Bronchopulmonary Dysplasia; Cardiomyopathy, Hypertrophic; Dexamethasone; Drug Therapy, Combination;	1996
[Therapy of hypertropic obstructive cardiomyopathy]. Deutsche medizinische Wochenschrift (1946), 1996, Nov-29, Volume: 121, Issue:48 Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Cardiomyopath	1996
The management of hypertrophic cardiomyopathy. The New England journal of medicine, 1997, Mar-13, Volume: 336, Issue:11 Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiomyopathy, Hypert	1997
[Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum]. Vnitrni lekarstvi, 2001, Volume: 47, Issue:12 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Hyp	2001
[Hypertrophic cardiomyopathy with obstruction]. Medizinische Klinik, 1979, Feb-09, Volume: 74, Issue:6 Topics: Adolescent; Adult; Aged; Angina Pectoris; Cardiac Glycosides; Cardiomyopathy, Hypertrophic; Coronary	1979
Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. Journal of the American College of Cardiology, 1991, Mar-01, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Child; Child, Presch	1991
Changes of the degree of hypertrophy in hypertrophic obstructive cardiomyopathy under medical and surgical treatment. Cardiology, 1989, Volume: 76, Issue:4 Topics: Adolescent; Adult; Aged; Cardiomegaly; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Echoca	1989
Calcium antagonists in cardiomyopathy. British journal of clinical practice. Supplement, 1988, Volume: 60 Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Humans; Verapamil	1988
Calcium channel blocking agents in congestive heart failure. The American journal of medicine, 1986, Feb-28, Volume: 80, Issue:2B Topics: Administration, Oral; Biological Transport; Calcium; Calcium Channel Blockers; Cardiac Output; Cardi	1986
Calcium antagonists in patients with cardiovascular disease. Current perspectives. Medicine, 1985, Volume: 64, Issue:1 Topics: Angina Pectoris; Angina Pectoris, Variant; Atrial Fibrillation; Atrial Flutter; Benzazepines; Cardio	1985
Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease. The American journal of cardiology, 1985, Jan-25, Volume: 55, Issue:3 Topics: Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Coronary Disease; Heart Ventricles; Hemodyna	1985
Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. The American journal of cardiology, 1985, Jan-25, Volume: 55, Issue:3 Topics: Animals; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Coronary Vasospasm; Cricetinae; Heart Failu	1985
Calcium channel blocking agents: physiologic basis of nursing intervention. Heart & lung : the journal of critical care, 1985, Volume: 14, Issue:4 Topics: Angina Pectoris; Angina Pectoris, Variant; Atrioventricular Node; Calcium; Calcium Channel Blockers;	1985

Article	Year
[Echocardiographic and electrocardiographic evaluation of the effects of propranolol and verapamil in obstructive hypertrophic cardiomyopathy]. Annales de cardiologie et d'angeiologie, 1984, Volume: 33, Issue:3 Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Clinical Trials as Topic; Echocardiography; Electrocardio	1984
Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy. Chest, 1980, Volume: 78, Issue:1 Suppl Topics: Adult; Aged; Aortic Stenosis, Subvalvular; Blood Pressure; Cardiac Output; Cardiomyopathy, Hypertrop	1980
Hypertrophic occlusive cardiomyopathy. Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2 Topics: Adolescent; Adult; Cardiac Volume; Cardiomyopathy, Hypertrophic; Clinical Trials as Topic; Dose-Resp	1980
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. Clinical and investigative medicine. Medecine clinique et experimentale, 1980, Volume: 3, Issue:1-2 Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiomyopathy, Hypertrophic; Clinical Trials as Topic;	1980
Therapeutic evaluation of pindolol and verapamil in hypertrophic obstructive cardiomyopathy. Giornale italiano di cardiologia, 1981, Volume: 11, Issue:11 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Pindolol; Verapa	1981
[Long-term treatment of hypertrophic non obstructive cardiomyopathy (HNCM) with verapamil (author's transl)]. Zeitschrift fur Kardiologie, 1980, Volume: 69, Issue:10 Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; Female	1980
Acute intravenous versus chronic oral drug effects of verapamil on left ventricular diastolic function in patients with hypertrophic cardiomyopathy. Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Cardiomyopathy, Hypertrophic; Female; Hemodynamics; Humans;	1994
Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. The American journal of cardiology, 1994, Aug-15, Volume: 74, Issue:4 Topics: Adult; Ammonia; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Double-Blind Metho	1994
A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 1993, Volume: 21, Issue:7 Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Double-Blind Method; Electrocardiography; Exe	1993
Verapamil normalizes the response of left ventricular early diastolic filling to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovascular drugs and therapy, 1997, Volume: 11, Issue:6 Topics: Adult; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cold Temperature; Echocardiography, D	1997
[Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy]. Klinicheskaia meditsina, 1998, Volume: 76, Issue:12 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Calcium Channel Blockers; Cardiomyopathy, Hype	1998
Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. Basic research in cardiology, 1999, Volume: 94, Issue:1 Topics: Adult; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Coronary Vessels; Dipyridamole; Femal	1999
Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:3 Topics: Adult; Blood Flow Velocity; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cold Temperature	1999
A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. Journal of the American College of Cardiology, 1999, Nov-15, Volume: 34, Issue:6 Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Child; Cohort S	1999
Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function. The Canadian journal of cardiology, 2000, Volume: 16, Issue:2 Topics: Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Diastole; Echocardi	2000
Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovascular drugs and therapy, 2000, Volume: 14, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers	2000
Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy. International journal of cardiology, 2002, Volume: 83, Issue:3 Topics: Adult; Blood Flow Velocity; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Coronary Circu	2002
[Hemodynamic and clinical studies with Bonnecor--a new anti-arrhythmia drug]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1990, Dec-01, Volume: 45, Issue:23 Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiomyopathy, H	1990
[Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil]. Archives des maladies du coeur et des vaisseaux, 1987, Volume: 80, Issue:1 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Electrocardiography; Exercise Test; Female; Humans;	1987
[Comparative study of the effects of verapamil and propranolol therapy in 16 cases of obstructive hypertrophic myocardiopathy]. Archives des maladies du coeur et des vaisseaux, 1987, Volume: 80, Issue:3 Topics: Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; Exercise Test; Female; Hemodyna	1987
[Effect of long-term treatment with verapamil on the clinical picture and exertion tolerance in patients with hypertrophic cardiomyopathy]. Kardiologia polska, 1987, Volume: 30, Issue:7 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Child; Clinical Trials as Topic; Double-Blind Metho	1987
Long-term treatment of hypertrophic cardiomyopathy with verapamil or propranolol in matched pairs of patients: results of a multicenter study. Zeitschrift fur Kardiologie, 1987, Volume: 76 Suppl 3 Topics: Cardiomyopathy, Hypertrophic; Clinical Trials as Topic; Echocardiography; Heart Rate; Humans; Propra	1987
Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study. Japanese heart journal, 1986, Volume: 27, Issue:5 Topics: Administration, Oral; Adult; Blood Pressure; Cardiomyopathy, Hypertrophic; Clinical Trials as Topic;	1986
Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. The American journal of cardiology, 1985, Jan-25, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Child; Clinical Tri	1985
Acute left ventricular filling time and rate changes in hypertrophic cardiomyopathy after verapamil and propranolol evaluated by nuclear stethoscope. Giornale italiano di cardiologia, 1985, Volume: 15, Issue:3 Topics: Adult; Cardiomyopathy, Hypertrophic; Heart; Heart Function Tests; Heart Rate; Hemodynamics; Humans;	1985

Article	Year
Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy. Circulation. Genomic and precision medicine, 2022, Volume: 15, Issue:4 Topics: Animals; Calcium; Cardiomegaly; Cardiomyopathy, Hypertrophic; Co-Repressor Proteins; Cytoskeletal Pr	2022
Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol. Circulation, 2023, Nov-21, Volume: 148, Issue:21 Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Carvedilol	2023
Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil. Circulation. Heart failure, 2013, Volume: 6, Issue:4 Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Surgica	2013
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. Journal of molecular and cellular cardiology, 2013, Volume: 63 Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic;	2013
Symptomatic obstructive hypertrophic cardiomyopathy. Circulation. Cardiovascular interventions, 2013, Oct-01, Volume: 6, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Cardiomyopathy, Hypertrophic; Diagnosis, Differential; Disease-Fr	2013
[Drug treatment for hypertrophic cardiomyopathy]. Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:6 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiomyop	2009
Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline. The American journal of cardiology, 2010, Nov-01, Volume: 106, Issue:9 Topics: Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Disopyramide; Echocardiography, D	2010
Exercise echocardiography in hypertrophic cardiomyopathy-upright evaluation needed. The American journal of cardiology, 2011, Apr-01, Volume: 107, Issue:7 Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Drug Therapy, C	2011
Diagnostic value of simultaneous non-invasive continuous, ambulatory finger blood pressure and electrocardiogram monitoring in a patient with hypertrophic obstructive cardiomyopathy. Blood pressure monitoring, 2002, Volume: 7, Issue:6 Topics: Anti-Arrhythmia Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiomyopathy, Hyper	2002
Reversal of acute pulmonary oedema with beta-blockers in hypertrophic cardiomyopathy. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2003, Volume: 4, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Echocard	2003
Sudden death due to atrial fibrillation in hypertrophic cardiomyopathy: a predictable event in a young patient. Pacing and clinical electrophysiology : PACE, 2003, Volume: 26, Issue:2 Pt 1 Topics: Adult; Amiodarone; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden, Cardiac; Defibr	2003
Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association? Clinical rheumatology, 2004, Volume: 23, Issue:1 Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cyclophosphamide; Drug Therapy, Co	2004
Transthoracic echocardiographic evaluation of coronary flow reserve in patients with hypertrophic cardiomyopathy. International journal of cardiology, 2004, Volume: 94, Issue:2-3 Topics: Adult; Blood Flow Velocity; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Coronary Circula	2004
Hypertrophic cardiomyopathy in systemic sclerosis. A report of two cases. Clinical rheumatology, 2006, Volume: 25, Issue:3 Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Heart Septum;	2006
Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy. Cardiology, 2007, Volume: 107, Issue:2 Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Defibrillators, Implantable; Heart Arre	2007
Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky. BMJ (Clinical research ed.), 2006, Jul-08, Volume: 333, Issue:7558 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Hypertroph	2006
Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart (British Cardiac Society), 2007, Volume: 93, Issue:6 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyop	2007
Long-term clinical effect of calcium inhibitors in hypertrophic cardiomyopathy compared to the effect of beta-blocking agents. A preliminary report with special reference to the beneficial effect of nifedipine on angina pectoris. Japanese heart journal, 1981, Volume: 22, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Calcium; Cardiomyopathy, Hypert	1981
Bizarre perceptual disorder of extremities in patients taking verapamil. Lancet (London, England), 1981, Jun-13, Volume: 1, Issue:8233 Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Perceptual Disorders; Verapa	1981
Therapy of hypertrophic cardiomyopathy: medical or surgical? clinical and pathophysiologic considerations. The American journal of cardiology, 1981, Volume: 48, Issue:2 Topics: Adrenergic beta-Antagonists; Calcium; Cardiomyopathy, Hypertrophic; Heart; Heart Conduction System;	1981
Welcome--the calcium channel blockers. Chest, 1981, Volume: 80, Issue:6 Topics: Adrenergic beta-Antagonists; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blocker	1981
Hypertrophic cardiomyopathy. Disease-a-month : DM, 1981, Volume: 28, Issue:2 Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cineangiography	1981
Verapamil in the treatment of hypertrophic cardiomyopathy. Annals of internal medicine, 1982, Volume: 96, Issue:5 Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Humans; Verapam	1982
[Clinical aspects, course and prognosis of various forms of hypertrophic cardiomyopathy]. Zeitschrift fur Kardiologie, 1983, Volume: 72, Issue:2 Topics: Adult; Blood Pressure; Cardiomegaly; Cardiomyopathy, Hypertrophic; Diagnosis, Differential; Electroc	1983
Verapamil for refractory ventricular fibrillation during cardiac operations in patients with cardiac hypertrophy. The Journal of thoracic and cardiovascular surgery, 1983, Volume: 86, Issue:1 Topics: Adolescent; Aortic Valve Stenosis; Cardiomegaly; Cardiomyopathy, Hypertrophic; Child; Child, Prescho	1983
[Experience with the treatment of patients with hypertrophic cardiomyopathy with obsidan and isoptin]. Kardiologiia, 1984, Volume: 24, Issue:8 Topics: Adolescent; Adult; Cardiomegaly; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Heart Septu	1984
[Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil]. Zeitschrift fur Kardiologie, 1983, Volume: 72, Issue:9 Topics: Adolescent; Adult; Cardiac Output; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiograp	1983
Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study. The American journal of cardiology, 1980, Volume: 45, Issue:1 Topics: Adolescent; Adult; Calcium; Cardiomegaly; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography;	1980
Obstructive hypertrophic cardiomyopathy with left-sided cardiac failure: improvement after verapamil treatment. The American journal of cardiology, 1984, Feb-01, Volume: 53, Issue:4 Topics: Aged; Cardiomyopathy, Hypertrophic; Humans; Male; Pulmonary Wedge Pressure; Verapamil	1984
Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy. British heart journal, 1984, Volume: 51, Issue:3 Topics: Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden; Electrocardiography; Heart Block;	1984
[Possibilities of a differentiated approach to the treatment of patients with idiopathic hypertrophic subaortic stenosis]. Vestnik Akademii meditsinskikh nauk SSSR, 1984, Issue:2 Topics: Adult; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Pr	1984
[Relaxation and regional myocardial stiffness in obstructive hypertrophic cardiopathy patients: effect of verapamil]. Giornale italiano di cardiologia, 1984, Volume: 14, Issue:2 Topics: Blood Pressure; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Heart Rate; Heart Ventricles	1984
Verapamil in hypertrophic cardiomyopathy. The American journal of cardiology, 1984, May-15, Volume: 53, Issue:10 Topics: Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Verapamil	1984
Hypertrophic obstructive cardiomyopathy. Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function. British heart journal, 1984, Volume: 51, Issue:5 Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Drug Administration Schedule; Female; Heart V	1984
Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy. The American journal of cardiology, 1984, Jun-01, Volume: 53, Issue:11 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Echocardiography; Electroc	1984
[The effect of verapamil on the left ventricular function in hypertrophic obstructive cardiomyopathy]. Zhonghua xin xue guan bing za zhi, 1984, Volume: 12, Issue:1 Topics: Administration, Oral; Adult; Cardiomyopathy, Hypertrophic; Female; Heart; Humans; Male; Middle Aged;	1984
Evaluation of the ocular safety of verapamil. Scheimpflug photography with densitometric image analysis of lens transparency in patients with hypertrophic cardiomyopathy subjected to long-term therapy with high doses of verapamil. Ophthalmic research, 1984, Volume: 16, Issue:5 Topics: Cardiomyopathy, Hypertrophic; Densitometry; Epidemiologic Methods; Humans; Lens, Crystalline; Ophtha	1984
[Risk of stress-induced ventricular arrhythmias in hypertrophic cardiomyopathy]. Zeitschrift fur Kardiologie, 1984, Volume: 73, Issue:5 Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Electrocardiography; Fe	1984
Decreased serum lithium during verapamil therapy. American heart journal, 1984, Volume: 108, Issue:5 Topics: Aged; Atrial Fibrillation; Bipolar Disorder; Cardiomyopathy, Hypertrophic; Female; Humans; Lithium;	1984
Calcium channel blockers. New treatment for cardiovascular disease. The American journal of nursing, 1983, Volume: 83, Issue:3 Topics: Adult; Angina Pectoris; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascu	1983
Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy. Circulation, 1983, Volume: 67, Issue:2 Topics: Adolescent; Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Hypertrophic; Child; Child, Presc	1983
Pressure-derived indices of left ventricular isovolumic relaxation in patients with hypertrophic cardiomyopathy. British heart journal, 1983, Volume: 49, Issue:3 Topics: Adult; Blood Pressure; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Female; Heart Ventr	1983
Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. The American journal of cardiology, 1983, May-01, Volume: 51, Issue:8 Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Diastole; Hemodynamics; Humans; Middle Aged; Myocardial C	1983
Calcium infusion for reversal of adverse effects of intravenous verapamil. JAMA, 1983, Jun-17, Volume: 249, Issue:23 Topics: Bradycardia; Calcium Chloride; Cardiomyopathy, Hypertrophic; Drug Synergism; Female; Humans; Hypoten	1983
Left ventricular end-diastolic pressure-volume relationships in hypertrophic cardiomyopathy. Changes induced by verapamil. Chest, 1983, Volume: 84, Issue:1 Topics: Adolescent; Adult; Blood Pressure; Cardiac Volume; Cardiomyopathy, Hypertrophic; Diastole; Female; H	1983
Influence of verapamil therapy on left ventricular performance at rest and during exercise in hypertrophic cardiomyopathy. The American journal of cardiology, 1983, Sep-01, Volume: 52, Issue:5 Topics: Adult; Cardiac Output; Cardiomyopathy, Hypertrophic; Female; Heart Rate; Heart Ventricles; Hemodynam	1983
Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe. Circulation, 1983, Volume: 68, Issue:5 Topics: Adult; Cardiac Volume; Cardiomyopathy, Hypertrophic; Depression, Chemical; Electrocardiography; Fema	1983
Calcium channel blocking agents. Council on scientific affairs. JAMA, 1983, Nov-11, Volume: 250, Issue:18 Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Asthma; Calcium Channel Blockers; Cardiomyopathy, Hy	1983
Effects of short-term administration of verapamil on left ventricular relaxation and filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy. Circulation, 1983, Volume: 68, Issue:6 Topics: Adult; Blood Pressure; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Echocardiography; Fema	1983
[Effect of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy]. Zhonghua nei ke za zhi, 1983, Volume: 22, Issue:7 Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Heart; Humans; Male; Middle Aged; Verapamil	1983
[Effect of verapamil on left ventricular function and exercise tolerance in hypertrophic cardiomyopathic patients]. Zhonghua xin xue guan bing za zhi, 1983, Volume: 11, Issue:3 Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Heart; Humans; Male; Middle Aged; Physical Exertion; Ve	1983
Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. European heart journal, 1983, Volume: 4 Suppl F Topics: Adult; Cardiomyopathy, Hypertrophic; Electrocardiography; Follow-Up Studies; Humans; Prognosis; Prop	1983
Long-term treatment of hypertrophic obstructive cardiomyopathy--usefulness of verapamil. European heart journal, 1983, Volume: 4 Suppl F Topics: Blood Pressure; Cardiac Catheterization; Cardiac Volume; Cardiomyopathy, Hypertrophic; Follow-Up Stu	1983
Exercise performance in hypertrophic cardiomyopathies. European heart journal, 1983, Volume: 4 Suppl F Topics: Adult; Cardiac Output; Cardiomyopathy, Hypertrophic; Exercise Test; Heart Rate; Humans; Middle Aged;	1983
Medical and surgical treatment of hypertrophic cardiomyopathy. European heart journal, 1983, Volume: 4 Suppl F Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathy, Hypertrophic; Child; Electric Countershock; Fem	1983
Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy. European heart journal, 1983, Volume: 4 Suppl F Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Female; Follow-Up Studies; Heart Septum; Humans; Ma	1983
Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness. European heart journal, 1983, Volume: 4 Suppl F Topics: Cardiomyopathy, Hypertrophic; Echocardiography; Heart Rate; Heart Ventricles; Humans; Myocardial Con	1983
The acute and chronic effects of verapamil on left ventricular function in patients with hypertrophic cardiomyopathy. European heart journal, 1983, Volume: 4 Suppl F Topics: Blood Pressure; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Depression, Chemical; Humans;	1983
Long-term effect of verapamil in hypertrophic cardiomyopathy. International journal of cardiology, 1982, Volume: 1, Issue:3-4 Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Echocardiography; Elect	1982
Hypertrophic apical cardiomyopathy: a subtype of hypertrophic cardiomyopathy. Israel journal of medical sciences, 1982, Volume: 18, Issue:10 Topics: Adult; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography;	1982
[Conservative medical treatment of hypertrophic myocardiopathies]. Zeitschrift fur Kardiologie, 1982, Volume: 71, Issue:12 Topics: Adolescent; Adult; Calcium Channel Blockers; Cardiac Catheterization; Cardiac Volume; Cardiomyopathy	1982
[Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy]. Zeitschrift fur Kardiologie, 1982, Volume: 71, Issue:12 Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Exercise Test; Female; Hemodynamics; Humans;	1982
Calcium antagonists for hypertrophic cardiomyopathy. JAMA, 1980, Apr-11, Volume: 243, Issue:14 Topics: Administration, Oral; Calcium; Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Injections, Intra	1980
Verapamil. A new class of antiarrhythmic agents with a variety of beneficial cardiovascular effects. Archives of internal medicine, 1980, Volume: 140, Issue:3 Topics: Arrhythmias, Cardiac; Calcium; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Heart; Human	1980
Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy. The American journal of cardiology, 1980, Volume: 45, Issue:6 Topics: Adult; Blood Pressure; Cardiomyopathy, Hypertrophic; Coronary Disease; Diastole; Echocardiography; F	1980
[Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl]. Zeitschrift fur Kardiologie, 1980, Volume: 69, Issue:10 Topics: Cardiac Volume; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Heart Septum; Heart Ventricl	1980
Idiopathic hypertrophic subaortic stenosis. American family physician, 1981, Volume: 24, Issue:1 Topics: Adult; Aged; Arrhythmias, Cardiac; Calcium; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; D	1981
Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation, 1981, Volume: 64, Issue:3 Topics: Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathy, Hypertrophic; Death, Sudden; Depression, Chemi	1981
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. The American journal of cardiology, 1981, Volume: 48, Issue:3 Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Echocardiography; Elect	1981
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. British heart journal, 1981, Volume: 46, Issue:2 Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; Female; Hu	1981
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation, 1981, Volume: 64, Issue:4 Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Diastole; Heart Rate; Heart Ventricles; Human	1981
[Verapamil in end-stage heart failure due to hypertrophic obstructive cardiopathy]. Harefuah, 1981, Apr-15, Volume: 100, Issue:8 Topics: Adult; Cardiomyopathy, Hypertrophic; Heart Failure; Hemodynamics; Humans; Male; Verapamil	1981
[Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)]. Journal of cardiography, 1981, Volume: 11, Issue:4 Topics: Adult; Cardiomyopathy, Hypertrophic; Echocardiography; Heart Rate; Humans; Middle Aged; Myocardial C	1981
[Importance of atrioventricular synchrony in hypertrophic obstructive cardiomyopathy treated by cardiac pacing]. Archives des maladies du coeur et des vaisseaux, 1995, Volume: 88, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Atrioventricular Node; Cardiac Pacing, Artificial; Cardiomyopathy	1995
[Hypertrophic cardiomyopathy: place and limitations of medical therapy]. Archives des maladies du coeur et des vaisseaux, 1995, Volume: 88, Issue:4 Suppl Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Calcium Channel Blocke	1995
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet (London, England), 1995, Jul-22, Volume: 346, Issue:8969 Topics: Aged; Angioplasty, Balloon, Coronary; Blood Pressure; Cardiac Catheterization; Cardiomyopathy, Hyper	1995
Symptomatic Japanese-type apical hypertrophic cardiomyopathy in a non-Asian patient: favorable response to treatment with verapamil. American heart journal, 1994, Volume: 128, Issue:3 Topics: Adult; Cardiomyopathy, Hypertrophic; Humans; Male; Verapamil	1994
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 1993, Volume: 22, Issue:3 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertro	1993
Diastolic compliance of hypertrophied ventricle is not acutely altered by pharmacologic agents influencing active processes. Annals of internal medicine, 1993, Sep-15, Volume: 119, Issue:6 Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Hypertrophic; Compliance; Diastole; Heart Ventricles; H	1993
Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease. The American journal of cardiology, 1993, Oct-15, Volume: 72, Issue:12 Topics: Adolescent; Adult; Bundle of His; Bundle-Branch Block; Cardiac Pacing, Artificial; Cardiomyopathy, D	1993
Reversal of cardiogenic shock and severe mitral regurgitation through verapamil in hypertensive hypertrophic cardiomyopathy. Chest, 1993, Volume: 104, Issue:1 Topics: Aged; Aortic Aneurysm, Abdominal; Aortic Rupture; Cardiomyopathy, Hypertrophic; Humans; Hypertension	1993
Doppler evidence of abnormal intracavitary systolic and diastolic flow in hypertrophic cardiomyopathy with midventricular obstruction. American heart journal, 1993, Volume: 126, Issue:2 Topics: Aged; Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Coronary Circulation; Echocardiography, Dop	1993
Effects on left ventricular function of pindolol added to verapamil in hypertrophic cardiomyopathy. The American journal of cardiology, 1993, Feb-01, Volume: 71, Issue:4 Topics: Adult; Analysis of Variance; Cardiomyopathy, Hypertrophic; Diastole; Drug Evaluation; Drug Therapy,	1993
[Effect of verapamil on myocardial ischemia in patients with hypertrophic cardiomyopathy: evaluation by exercise 201Tl SPECT]. Kaku igaku. The Japanese journal of nuclear medicine, 1993, Volume: 30, Issue:1 Topics: Adult; Blood Pressure; Cardiomyopathy, Hypertrophic; Exercise Test; Female; Heart; Heart Rate; Human	1993
The acute response of left ventricular filling dynamics to intravenous verapamil predicts the changes in exercise tolerance after oral verapamil therapy in patients with hypertrophic cardiomyopathy. European heart journal, 1993, Volume: 14, Issue:3 Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Hypertrophic; Diastole; Exercise Tolerance; Femal	1993
[Effects of verapamil on left ventricular diastolic dysfunction]. Zhonghua nei ke za zhi, 1995, Volume: 34, Issue:6 Topics: Adolescent; Adult; Aged; Calcium Channel Blockers; Cardiac Catheterization; Cardiomyopathy, Hypertro	1995
Congenital hypertrophic cardiomyopathy associated with in utero verapamil exposure. Prenatal diagnosis, 1995, Volume: 15, Issue:11 Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Maternal-Fetal Exchange; Pregnancy; Verapamil	1995
Persisting effect of Ca(2+)-channel blockers on left ventricular function in hypertrophic cardiomyopathy after 14 years' treatment. Angiology, 1996, Volume: 47, Issue:8 Topics: Adult; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Echocardiography, Doppler, Pulsed; Ex	1996
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart and vessels, 1996, Volume: 11, Issue:3 Topics: Adult; Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Echoca	1996
Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathy. Circulation, 1996, Dec-01, Volume: 94, Issue:11 Topics: Adult; Aging; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Echocardiography; Humans; Middl	1996
Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6. European journal of pharmacology, 1997, Jun-11, Volume: 328, Issue:2-3 Topics: Animals; Calcium; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cricetinae; Heart Ventricl	1997
Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy--the lobster claw abnormality. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 1997, Volume: 10, Issue:7 Topics: Acceleration; Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Blood Flow Velocity; Calciu	1997
Potential macrolide interaction with verapamil. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:3 Topics: Aged; Anti-Bacterial Agents; Cardiomyopathy, Hypertrophic; Contraindications; Drug Interactions; Fem	1998
Verapamil therapy in infants with hypertrophic cardiomyopathy. Cardiology in the young, 1998, Volume: 8, Issue:3 Topics: Administration, Oral; Cardiomyopathy, Hypertrophic; Diagnosis, Differential; Electrocardiography, Am	1998
[Transcoronary ablation of septal hypertrophy (TASH): supersedes it the surgery (myectomy)?]. Herz, 1999, Volume: 24, Issue:8 Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic	1999
Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart (British Cardiac Society), 2000, Volume: 83, Issue:3 Topics: Adult; Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Case-Control Studies; Coronary Circulation	2000
The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patients with hypertrophic cardiomyopathy. Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:4 Topics: Adult; Blood Pressure; Cardiomyopathy, Hypertrophic; Coronary Circulation; Exercise Test; Female; Ha	2001
[Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)]. Deutsche medizinische Wochenschrift (1946), 1976, Aug-27, Volume: 101, Issue:35 Topics: Adrenergic beta-Antagonists; Adult; Calcium; Cardiac Volume; Cardiomyopathy, Hypertrophic; Drug Eval	1976
[Do guide lines for differential therapy in hypertrophic obstructive cardiomyopathy exits?]. Cardiology, 1978, Volume: 63 Suppl 1 Topics: Adrenergic beta-Antagonists; Calcium; Cardiomyopathy, Hypertrophic; Drug Administration Schedule; Hu	1978
[Obstructive hypertrophic cardiomyopathy: excito-conduction disturbances and sudden death (author's transl)]. Giornale italiano di cardiologia, 1977, Volume: 7, Issue:5 Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Electrocardiography; Femal	1977
[Reduction of coronary artery cross section during conservative therapy of hypertrophic obstructive cardiomyopathy]. Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1977, Volume: 43 Topics: Arteries; Cardiomyopathy, Hypertrophic; Coronary Vessels; Humans; Verapamil	1977
[Echocardiographic and hemodynamic studies on the influence of verapamil in hypertrophic obstructive cardiomyopathy (author's transl)]. Zeitschrift fur Kardiologie, 1979, Volume: 68, Issue:2 Topics: Blood Pressure; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocard	1979
Treatment of hypertrophic obstructive cardiomyopathy with verapamil. British heart journal, 1979, Volume: 42, Issue:1 Topics: Adult; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Coronary Angiography; Coronary Vessels	1979
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation, 1979, Volume: 60, Issue:6 Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cardiomyopathy, Hypertrophic; Coronary Circulation; Fem	1979
Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. Circulation, 1979, Volume: 60, Issue:6 Topics: Adult; Cardiomyopathy, Hypertrophic; Double-Blind Method; Female; Follow-Up Studies; Heart Rate; Hum	1979
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation, 1992, Volume: 85, Issue:6 Topics: Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy, Hy	1992
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation, 1992, Volume: 85, Issue:6 Topics: Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy, Hy	1992
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation, 1992, Volume: 85, Issue:6 Topics: Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy, Hy	1992
Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation, 1992, Volume: 85, Issue:6 Topics: Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy, Hy	1992
Influence of verapamil on the coronary arteriovenous difference in long chain free fatty acids in hypertrophic cardiomyopathy. European journal of clinical pharmacology, 1992, Volume: 42, Issue:2 Topics: Adult; Cardiomyopathy, Hypertrophic; Coronary Circulation; Coronary Vessels; Fatty Acids, Nonesterif	1992
Evolution of the electrocardiographic changes in patients with hypertrophic cardiomyopathy. Clinical cardiology, 1991, Volume: 14, Issue:11 Topics: Adolescent; Adult; Age Factors; Cardiomyopathy, Hypertrophic; Causality; Child; Echocardiography; El	1991
[Effects of verapamil on the left ventricular diastolic function and diastolic asynchrony in patients with hypertrophic cardiomyopathy]. Journal of cardiology, 1991, Volume: 21, Issue:1 Topics: Adult; Aged; Blood Pressure; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography; Female; Heart	1991
A reduction in verapamil concentrations with phenytoin. The New England journal of medicine, 1991, Oct-17, Volume: 325, Issue:16 Topics: Adult; Cardiomyopathy, Hypertrophic; Drug Interactions; Epilepsy; Female; Humans; Phenytoin; Verapam	1991
[Progress in the treatment of myocardial diseases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Mar-10, Volume: 79, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Di	1990
Surgical versus medical therapy of hypertrophic cardiomyopathy: is the perspective changing? Journal of the American College of Cardiology, 1991, Mar-01, Volume: 17, Issue:3 Topics: Cardiomyopathy, Hypertrophic; Humans; Propranolol; Survival Rate; Verapamil	1991
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. The Journal of clinical investigation, 1991, Volume: 87, Issue:3 Topics: Adult; Aged; Caffeine; Calcium; Cardiomyopathy, Hypertrophic; Colforsin; Diastole; Female; Hemodynam	1991
[Calcium antagonists in cardiomyopathy]. Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49, Issue:1 Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Coronary Circulatio	1991
Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients. Cardiovascular drugs and therapy, 1990, Volume: 4, Issue:6 Topics: Adult; Cardiomyopathy, Hypertrophic; Death, Sudden; Follow-Up Studies; Humans; Prognosis; Propranolo	1990
[Washout rate in patients with hypertrophic cardiomyopathy and hypertensive cardiac hypertrophy]. Journal of cardiology, 1990, Volume: 20, Issue:2 Topics: Cardiomegaly; Cardiomyopathy, Hypertrophic; Echocardiography; Exercise Test; Female; Heart; Humans;	1990
Reversal of cardiogenic shock and asystole in a septic patient with hypertrophic cardiomyopathy on verapamil. Critical care medicine, 1990, Volume: 18, Issue:7 Topics: Adolescent; Arrhythmias, Cardiac; Calcium Chloride; Cardiomyopathy, Hypertrophic; Critical Care; Hea	1990
Regression of outflow tract obstruction subsequent to treatment with verapamil in hypertrophic obstructive cardiomyopathy. International journal of cardiology, 1990, Volume: 28, Issue:3 Topics: Adult; Cardiomyopathy, Hypertrophic; Electrocardiography; Humans; Male; Stroke Volume; Systole; Vera	1990
[Systolic and diastolic intervals in patients with hypertrophic obstructive cardiomyopathy before and after withdrawal of verapamil]. Bratislavske lekarske listy, 1990, Volume: 91, Issue:9 Topics: Cardiomyopathy, Hypertrophic; Diastole; Electrocardiography; Humans; Kinetocardiography; Myocardial	1990
Doppler evaluation of left ventricular filling: effect of verapamil on non-obstructive hypertrophic cardiomyopathy. European heart journal, 1990, Volume: 11, Issue:9 Topics: Aged; Cardiomyopathy, Hypertrophic; Echocardiography, Doppler; Female; Humans; Male; Ventricular Fun	1990
Oral verapamil effects on global and regional left ventricular diastolic filling in hypertrophic cardiomyopathy. Japanese circulation journal, 1990, Volume: 54, Issue:11 Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography; Female;	1990
Calcium channel blocking drugs. Part II: Clinical applications. Comprehensive therapy, 1985, Volume: 11, Issue:10 Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Arrhythmias, Cardiac; Calcium Channel B	1985
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. Herz, 1985, Volume: 10, Issue:2 Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Pr	1985
[Treatment of cardiomyopathy using Ca blockers]. Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:8 Topics: Animals; Calcium Channel Blockers; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cricetinae	1989
[Long-term course of hypertrophic cardiomyopathy: drug versus surgical therapy]. Schweizerische medizinische Wochenschrift, 1989, Oct-28, Volume: 119, Issue:43 Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Heart Septum; Humans; Longitudinal Studies; Male; Progn	1989
[Results of long-term verapamil treatment of patients with hypertrophic cardiomyopathy]. Kardiologia polska, 1989, Volume: 32 Suppl 2 Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardi	1989
Sustained ventricular tachycardia responsive to verapamil in patients with hypertrophic cardiomyopathy. Clinical and electrophysiological assessment of drug efficacy. Japanese heart journal, 1989, Volume: 30, Issue:2 Topics: Adult; Cardiomyopathy, Hypertrophic; Electrocardiography; Electrophysiology; Female; Humans; Male; M	1989
Myocardial stunning in hypertrophic cardiomyopathy: recovery predicted by single photon emission computed tomographic thallium-201 scintigraphy. Journal of the American College of Cardiology, 1989, Volume: 13, Issue:6 Topics: Adult; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart; Humans; Myocardial Contraction	1989
Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation, 1989, Volume: 79, Issue:5 Topics: Adult; Cardiomyopathy, Hypertrophic; Coronary Circulation; Coronary Disease; Echocardiography; Exerc	1989
[Beta adrenergic receptors in patients with untreated and verapamil-treated hypertrophic cardiomyopathy]. Sbornik lekarsky, 1988, Volume: 90, Issue:7 Topics: Cardiomyopathy, Hypertrophic; Humans; Lymphocytes; Receptors, Adrenergic, beta; Verapamil	1988
[Treatment of hypertrophic cardiomyopathy]. Annales de cardiologie et d'angeiologie, 1985, Volume: 34, Issue:10 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Echo	1985
[Treatment of hypertrophic myocardiopathies]. Presse medicale (Paris, France : 1983), 1986, Sep-27, Volume: 15, Issue:32 Topics: Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Echocardiography; Endocarditis, Bacterial; Human	1986
Myocardial biopsy in patients with hypertrophic cardiomyopathy: correlations between morphologic and clinical parameters and development of myocardial hypertrophy under medical therapy. Zeitschrift fur Kardiologie, 1987, Volume: 76 Suppl 3 Topics: Adult; Biopsy; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cell Nucleus; Female; Humans; Male; Middl	1987
Calcium antagonist receptors in cardiomyopathic hamster: selective increases in heart, muscle, brain. Science (New York, N.Y.), 1986, Apr-25, Volume: 232, Issue:4749 Topics: Animals; Brain; Brain Chemistry; Calcium; Calcium Channels; Cardiomyopathy, Hypertrophic; Cricetinae	1986
[Doppler evaluation of left ventricular diastolic filling after intravenous injection of verapamil in patients with hypertrophic cardiomyopathy]. Zhonghua nei ke za zhi, 1988, Volume: 27, Issue:7 Topics: Adult; Cardiomyopathy, Hypertrophic; Diastole; Female; Humans; Injections, Intravenous; Male; Middle	1988
[Obstructive myocardiopathy in the elderly. A retrospective study of 18 cases]. Presse medicale (Paris, France : 1983), 1985, Mar-30, Volume: 14, Issue:13 Topics: Aged; Cardiomyopathy, Hypertrophic; Echocardiography; Electrocardiography; Female; Hemodynamics; Hum	1985
[Calcium antagonists in hypertrophic cardiomyopathy]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, Oct-31, Volume: 43, Issue:44 Topics: Cardiomyopathy, Hypertrophic; Drug Evaluation; Humans; Nifedipine; Verapamil	1988
Effects of verapamil on left ventricular diastolic filling in children with hypertrophic cardiomyopathy. The American journal of cardiology, 1988, Feb-15, Volume: 61, Issue:6 Topics: Administration, Oral; Adolescent; Cardiomyopathy, Hypertrophic; Child; Exercise Test; Follow-Up Stud	1988
[Hemodynamic effects of intravenous verapamil in patients with obstructive myocardiopathy]. Revista espanola de cardiologia, 1988, Volume: 41, Issue:1 Topics: Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Drug Evalua	1988
[Importance of current ultrasonic study methods for the diagnosis, follow-up of treatment effectiveness and prognosis of patients with hypertrophic obstructive cardiomyopathy]. Terapevticheskii arkhiv, 1987, Volume: 59, Issue:10 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Drug Evaluation; Echocardiography; Female; Follow-U	1987
Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies. Zeitschrift fur Kardiologie, 1987, Volume: 76 Suppl 3 Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Female; Follow-Up Studies; Hemodynamics; Huma	1987
Radionuclide ventriculography: acute and chronic response to verapamil in patients with hypertrophic cardiomyopathy. Zeitschrift fur Kardiologie, 1987, Volume: 76 Suppl 3 Topics: Acute Disease; Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Chronic Disease; Diastole; Fem	1987
[Non-obstructive hypertrophic cardiomyopathy and systolic compression of 3 coronary arteries. Long-term improvement with verapamil]. Annales de medecine interne, 1987, Volume: 138, Issue:7 Topics: Adult; Cardiomyopathy, Hypertrophic; Constriction, Pathologic; Coronary Disease; Echocardiography; E	1987
Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Journal of the American College of Cardiology, 1987, Volume: 9, Issue:5 Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Coronary Circulation; Female; Heart; Heart Atria; Heart V	1987
Verapamil-induced ventricular tachycardia in hypertrophic cardiomyopathy. European heart journal, 1987, Volume: 8, Issue:3 Topics: Adolescent; Cardiomyopathy, Hypertrophic; Humans; Male; Tachycardia; Verapamil	1987
Orthostatic hypotension due to hypertrophic cardiomyopathy and autonomic failure. The American journal of medicine, 1987, Volume: 82, Issue:6 Topics: Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Cardiomyopathy, Hypertrophic; Echocardio	1987
[Effect of single-dose verapamil on ventricular wall movement in hypertrophic cardiomyopathy]. Zhonghua xin xue guan bing za zhi, 1987, Volume: 15, Issue:1 Topics: Administration, Oral; Adult; Cardiomyopathy, Hypertrophic; Echocardiography; Female; Humans; Male; M	1987
[Acute and chronic effects of verapamil on indices of systolic and diastolic function of the left ventricle in patients with hypertrophic cardiomyopathy]. Giornale italiano di cardiologia, 1987, Volume: 17, Issue:9 Topics: Adult; Aged; Angiocardiography; Cardiomyopathy, Hypertrophic; Diastole; Female; Heart; Humans; Male;	1987
Verapamil, syncope, and hypertrophic obstructive cardiomyopathy. The New England journal of medicine, 1986, Jun-12, Volume: 314, Issue:24 Topics: Cardiomyopathy, Hypertrophic; Constipation; Humans; Male; Middle Aged; Syncope; Verapamil	1986
[Hypertrophic cardiomyopathy in childhood: studies of the clinical picture and course]. Zeitschrift fur Kardiologie, 1986, Volume: 75, Issue:7 Topics: Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Echocardiography; El	1986
[Effect of verapamil on the indicators of left-ventricular diastole in hypertrophic cardiomyopathy]. Kardiologia polska, 1986, Volume: 29, Issue:5-6 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Diastole; Female; Heart Ventricles; Humans; Male; M	1986
Hypertension with marked left ventricular hypertrophy. Journal of clinical hypertension, 1986, Volume: 2, Issue:3 Suppl Topics: Aged; Cardiomyopathy, Hypertrophic; Female; Humans; Hypertension; Radionuclide Imaging; Verapamil	1986
Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy. British heart journal, 1986, Volume: 56, Issue:6 Topics: Adolescent; Adult; Blood Pressure; Cardiomyopathy, Hypertrophic; Female; Heart Rate; Hemodynamics; H	1986
Effects of verapamil on left ventricular diastolic function at rest and during isometric exercise in patients with hypertrophic cardiomyopathy. Clinical cardiology, 1987, Volume: 10, Issue:1 Topics: Adult; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography; Female; Heart Ventricles; Humans; I	1987
[Personal experience with the long-term administration of verapamil in hypertrophic cardiomyopathies]. Vnitrni lekarstvi, 1986, Volume: 32, Issue:12 Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Time Factors; Ve	1986
[Does verapamil affect the thickness of the cardiac muscle in hypertrophic cardiomyopathy?]. Vnitrni lekarstvi, 1986, Volume: 32, Issue:12 Topics: Adult; Cardiomyopathy, Hypertrophic; Heart; Humans; Myocardium; Verapamil	1986
[Left ventricular relaxation in hypertrophic cardiomyopathy and possibilities of controlling it with verapamil]. Casopis lekaru ceskych, 1987, Mar-13, Volume: 126, Issue:11 Topics: Adult; Cardiomyopathy, Hypertrophic; Female; Heart Ventricles; Humans; Male; Myocardial Contraction;	1987
Use of verapamil in the treatment of hypertrophic cardiomyopathy. Cor et vasa, 1986, Volume: 28, Issue:6 Topics: Adolescent; Adult; Cardiac Output; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged;	1986
Role of calcium in the induction of cardiac hypertrophy and myofibrillar disarray. Experimental studies of a possible cause of hypertrophic cardiomyopathy. British heart journal, 1985, Volume: 54, Issue:4 Topics: Animals; Calcimycin; Calcium; Cardiomyopathy, Hypertrophic; Female; Heart; Microscopy, Electron; Myo	1985
Isovolumic relaxation period in hypertrophic cardiomyopathy: assessment by radionuclide angiography. Journal of the American College of Cardiology, 1986, Volume: 7, Issue:1 Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Constriction, Pathologic; Echocardiography; Female; Heart	1986
Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 1986, Volume: 7, Issue:3 Topics: Adolescent; Atrial Fibrillation; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiomyopathy	1986
Use of calcium channel blockers in hypertrophic cardiomyopathy. The American journal of medicine, 1985, Feb-22, Volume: 78, Issue:2B Topics: Biomechanical Phenomena; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Heart Ventricles; H	1985
Adverse effects of atrial fibrillation and syncope induced by calcium-channel blockers in hypertrophic cardiomyopathy. Clinical cardiology, 1985, Volume: 8, Issue:3 Topics: Adult; Atrial Fibrillation; Benzazepines; Cardiomyopathy, Hypertrophic; Diltiazem; Echocardiography;	1985
[Drug treatment of hypertrophic cardiomyopathy]. Herz, 1985, Volume: 10, Issue:2 Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Electrocardiography	1985
Usefulness of Doppler echocardiography for determining hemodynamic improvement with intravenous verapamil in hypertrophic cardiomyopathy. The American journal of cardiology, 1985, Jul-01, Volume: 56, Issue:1 Topics: Adolescent; Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Hypertrophic; Echocardiography; Fem	1985
Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation, 1985, Volume: 72, Issue:4 Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography; Female; Heart Ven	1985
Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms. Journal of molecular and cellular cardiology, 1985, Volume: 17 Suppl 2 Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Catheterization; Cardio	1985
Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium. Anesthesia and analgesia, 1985, Volume: 64, Issue:10 Topics: Anesthesia; Cardiomyopathy, Hypertrophic; Cholecystectomy; Drug Synergism; Edrophonium; Humans; Male	1985
[Myocardial hypertrophy: regression in hypertrophic cardiomyopathies?]. Zeitschrift fur Kardiologie, 1985, Volume: 74 Suppl 7 Topics: Animals; Cardiac Volume; Cardiomyopathy, Hypertrophic; Echocardiography; Heart Septum; Heart Ventric	1985